Dallah Healthcare Company announced that its board of directors has approved the resignation of the board member, Dr. Fahad bin Abdulaziz Al-Rabiah, from the membership of the board of directors and compensation and remuneration committee, effective from November 15, 2022 due to his personal reasons.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
162 SAR | 0.00% | -0.74% | -5.70% |
Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.70% | 4.22B | |
-18.46% | 16.57B | |
+4.50% | 12.51B | |
+4.31% | 11.69B | |
+5.36% | 10.36B | |
+24.72% | 8.38B | |
-2.64% | 7.75B | |
+20.04% | 7.16B | |
+4.17% | 6.6B | |
+46.90% | 4.54B |
- Stock Market
- Equities
- 4004 Stock
- News Dallah Healthcare Company
- Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee